VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1791862
Sex: F
Age:
State: MA

Vax Date: 03/07/2021
Onset Date: 03/07/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: After 16 hours, onset of nausea; Chill; Muscle aches; Tired; Very swollen lymph node under left arm; Day 1 - headache for first 16 hours; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took fluconazole (DIFLUCAN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and daily iron supplement (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 14Feb2021 at 11:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 07Mar2021, the patient experienced headache for first 16 hours and sore arm. On 08Mar2021 at 02:00,after 16 hours, the patient experienced nausea, chill, muscle aches, tired and very swollen lymph node under left arm. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 08Mar2021; while that of event sore arm, nausea, chill, muscle aches, tired and very swollen lymph node under left arm were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1791863
Sex: F
Age:
State: IL

Vax Date: 02/24/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Swollen lymph nodes above left clavicle; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 24Feb2021 at 10:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and high blood pressure. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), chlortalidone (MANUFACTURER UNKNOWN) and omeprazole (PRILOSEC) all for unknown indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Mar2021, the patient experienced swollen lymph nodes above left clavicle. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event swollen lymph nodes above left clavicle was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; AMLODIPINE; CHLORTHALIDONE; PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1791864
Sex: F
Age:
State: OK

Vax Date: 02/26/2021
Onset Date: 03/06/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Large inflamed lymph node in front of neck starting 8 days after vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 09:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included dermatomyositis, migraine and allergy to sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included naltrexone (MANUFACTURER UNKNOWN), estradiol (MINIVELLE) and sumatriptan (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. On 06Mar2021 at 10:00, the patient experienced large inflamed lymph node in front of neck starting 8 days after vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event large inflamed lymph node in front of neck was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: NALTREXONE; MINIVELLE; SUMATRIPTAN

Current Illness:

ID: 1791865
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Groggy; Mild dizziness; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 08Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, sinusitis, rhinitis, latex allergy and allergy to bee stings, tree nuts, peanuts, nightshades, apricots. The patient was allergic to codeine (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Asthma Meds (unspecified), Zyrtec (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. On 08Mar2021 at 12:30, the patient experienced groggy, exhaustion and mild dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events groggy, exhaustion and mild dizziness was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1791866
Sex: M
Age:
State: FL

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache for the past day started around 2 hours after vaccination; Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included Retinoblastoma 1 (RB1) mutation diagnosed at birth, Retinoblastoma (RB) history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pseudoephedrine hydrochloride (MANUFACTURER UNKNOWN) 120mg taken for an unknown indication from an unknown date and unknown if ongoing. On 08Mar2021 at 18:30, around 2 hours after vaccination, the patient experienced headache for the same day and sore left arm; nothing major besides headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and sore left arm were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PSEUDOEPHEDRINE HYDROCHLORIDE

Current Illness:

ID: 1791867
Sex: F
Age:
State: NJ

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Head pressure; Light sensitivity; Extreme anxiety; Fatigue; Nausea; Vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 17:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), dysautonomia, lyme disease, antiphospholipid syndrome and sulfonamide allergy (sulfa abx). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 20:00, the patient experienced head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791868
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210309; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknown

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Diarrhea; This is a spontaneous report from a contactable consumer. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN), propranolol (MANUFACTURER UNKNOWN) and multi vit (MANUFACTURER UNKNOWN) all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 09Mar2021 at 14:00 the patient experienced diarrhea. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 09Mar2021, the patient underwent lab test and procedures which included nasal swab and the result was unknown. The clinical outcome of the event diarrhea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CLONAZEPAM; PROPRANOLOL

Current Illness:

ID: 1791869
Sex: M
Age:
State:

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Soreness at injection site (upper left arm); This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 at 10:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included peripheral neuropathy and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 04Mar2021, the patient experienced soreness at injection site (upper left arm). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness at injection site (upper left arm) was recovered on unknown date in Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791870
Sex: F
Age:
State: AZ

Vax Date: 02/25/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 25Feb2021 at 09:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included alendronate sodium (ALENDRONATE) and colecalciferol/calcium citrate (CALCIUM CITRATE + D3) on an unknown date for an unknown indication and unknown if ongoing. On 27Feb2021, the patient experienced sore left arm. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left arm was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALENDRONATE; CALCIUM CITRATE + D3

Current Illness:

ID: 1791871
Sex: F
Age:
State: TX

Vax Date: 03/03/2021
Onset Date: 03/05/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6200), at the age of 30, via an unspecified route of administration, in the left arm, on Mar 3, 2021, at 15:30, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 5, 2021, at 09:00, patient experienced swollen lymph node in left armpit (injection arm). The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures taken as a result of the reported event. Since the vaccination, patient has not tested for COVID-19. The outcome of swollen lymph node in left armpit (injection arm) recovered on an unknown date in Mar 2021. No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1791872
Sex: M
Age:
State: FL

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: After second vaccine, I had a severe migraine headache the day after. Been three weeks since second dose, and have had a migraine every day to varying degrees since then. I've gotten migraines before, but never to this extent.; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Feb2021 at 09:15 (at the age of 68-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications within two weeks of vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Jan2021 at 12:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 16Feb2021 at 08:00, the patient experienced had a severe migraine headache the day after. It had been three weeks since second dose and had a migraine every day to varying degrees since then. The patient got migraines before, but never to this extent. Therapeutic measures were taken as a result of migraine headache and included treatment with aspirin (MANUFACTURER UNKNOWN) and other type of pain medications from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine headache was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791873
Sex: M
Age:
State: TX

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Sore arm; Fatigue; Little disoriented; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 00:00 as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN); from an unknown date for an unknown indication and was unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 08Mar2021 at 15:00, the patient experienced sore arm, facial muscles, fatigue and a little disoriented. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events sore arm, facial muscles, fatigue and little disoriented was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1791874
Sex: F
Age:
State: VA

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: No desire to eat; The next day "I" did not feel the pressure "I" have felt due to COPD. The heavy tight pressure on "my" chest from COPD was gone.; Lack of energy; "I" feel spacey, sometimes dizzy.; "I" feel spacey, sometimes dizzy.; "I" will say "I" have been so very very tired since shot and now going on day 3; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 04:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy, sulfa drug allergy, chronic obstructive pulmonary disease (COPD), asthma and heavy tight chest pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), tiotropium bromide monohydrate (SPIRIVA), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin(unspecified), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took minocycline hydrochloride (MINOCIN), cefoxitin (MANUFACTURER UNKNOWN) cefaclor (CECLOR) from an unknown date and experienced allergy. On 06Mar2021, since the shot, the patient had been so very very tired and was going on day 3 at the time of report. The patient had reported that first there was a good event on 07Mar2021 at 08:00, the next day after vaccination, the patient did not feel the pressure she had felt due to chronic obstructive pulmonary disease (COPD). The heavy tight pressure on her chest from COPD was gone. It was reported that the patient had COPD for a long time and had forgotten how it felt not to have had the pressure on her chest. She reported that it was amazing and it was a miracle. On 07Mar2021, the patient felt spacey, sometimes dizzy, no desire to eat and lack of energy. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event did not feel the pressure that was felt due to COPD was unknown, while the clinical outcome of very very tired, felt spacey, sometimes dizzy, no desire to eat and lack of energy were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADVAIR; SPIRIVA; ATORVASTATIN

Current Illness:

ID: 1791875
Sex: F
Age:
State: NM

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210226; Test Name: BP; Result Unstructured Data: Test Result:140/106; Test Date: 20210226; Test Name: HR; Result Unstructured Data: Test Result:77; Test Date: 20210226; Test Name: Sao2; Test Result: 97 %

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: felt hot; sweaty; queasy; 140/106-b/p; This is a spontaneous report from a contactable other hcp. A 51-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular on 26Feb2021 15:00 (Age at vaccination 51 years old) (Batch/Lot Number: EN6203) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Penicillin. The patient's concomitant medications were not reported. on 26Feb2021 15:00 the patient experienced felt hot, sweaty, queasy, 140/106-b/p. The patient underwent lab tests and procedures which included blood pressure measurement: 140/106 on 26Feb2021, heart rate: 77 on 26Feb2021, oxygen saturation: 97 % on 26Feb2021. Outcome of the events was recovered on unspecified date of 2021. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791876
Sex: F
Age:
State: AL

Vax Date: 02/25/2021
Onset Date: 03/05/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: The day I was vaccinated I had the usual soreness at the injection site and for the next day; Headache; Lymph nodes at the back of my neck were swollen; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZN6205) via an unspecified route of administration in the arm left on 25Feb2021 at 15:45 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications taken within two weeks included fexofenadine hydrochloride (ALLEGRA) from an unknown date for an unknown indication. On 05Mar2021 at 03:30, on the day of vaccination, the patient experienced usual soreness at the injection site and for the next day. A week after she got the shot she got a headache so bad she had to take Tylenol for it but she also noticed her lymph nodes at the back of her neck were swollen, she called her daughter, she's working on her PHD in infectious diseases, and told her about her swollen lymph nodes and her daughter told her that she need to report it. The daughter told that means the vaccine was working and her body was doing what it's suppose to be doing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events vaccination site pain, headache and swollen lymph nodes and included treatment with paracetmol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vaccination site pain, headache and swollen lymph nodes was resolved in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1791877
Sex: F
Age:
State: UT

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Metallic taste; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 16:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and allergies to cillin based medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lansoprazole (PREVACID), pioglitazone (MANUFACTURER UNKNOWN) and unspecified birth control; all for an unknown indication from an unknown date and unknown if ongoing. On 09Mar2021 at 17:00, the patient experienced metallic taste. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event metallic taste was resolved on an unknown date in Mar2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PREVACID; PIOGLITAZONE

Current Illness:

ID: 1791878
Sex: M
Age:
State: PA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Muscle soreness at injection site (left arm); Muscle soreness (left arm); This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 25Feb2021 at 15:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported was not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 25Feb2021 at 19:00, the patient experienced muscle soreness at injection site (left arm). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event muscle soreness at injection site (left arm) was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791879
Sex: F
Age:
State: VT

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Fatigue; Headache; Pain at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 03Mar2021 at 17:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to steroids. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paroxetine (MANUFACTURER UNKNOWN), zaleplon (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), withania somnifera (ASHWAGANDHA) and ibuprofen (IBUPROF); all taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021 the patient experienced fatigue, headache and pain at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, headache and pain at injection site was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: PAROXETINE; ZALEPLON; VIT D [VITAMIN D NOS]; ASHWAGANDHA; IBUPROF

Current Illness:

ID: 1791880
Sex: F
Age:
State: WI

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Tenderness at the injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 03Mar2021 at 09:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and heights (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 17:00, the patient experienced tenderness at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tenderness at the injection site was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: BUPROPION; SPIRONOLACTONE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1791881
Sex: F
Age:
State: NJ

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Flu like systems; Headache; Body aches; Fatigue; Nausea; Painful arm; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Eng6203) via an unspecified route of administration in the right arm on 03Mar2021 at 07:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included diabetes, fibromyalgia, allergy to opioids and the patient was a breast cancer survivor. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), losartan potassium (LOSARTIN) and atenolol (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received tetracycline (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN) and amoxicillin/clavulanic acid (AUGMENTIN) and experienced allergy. On 03Mar2021 at 13:00, the patient experienced flu like symptoms, headache, body aches, fatigue, nausea and painful arm. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, headache, body aches, fatigue, nausea and painful arm was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; ATORVASTATIN; LOSARTIN; ATENOLOL

Current Illness:

ID: 1791882
Sex: F
Age:
State: UT

Vax Date: 02/06/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Swollen lymph nodes in left axils of left arm.; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9269) via an unspecified route of administration on 06Feb2021 at 17:15 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included helicobacter pylori (HP) infection under control with meds. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 27Feb2021 at 17:15, the patient experienced swollen lymph nodes in the left axils of the left arm and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes in the left axils of the left arm and tiredness were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791883
Sex: M
Age:
State: CA

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20201030; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Unevaluable event

Symptoms: severe dizziness; vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old male patient received first dose of BNT162b2 (COMIRNATY, Lot number: EN6199) via an unspecified route of administration on the left arm on 14Feb2021 at 10:15 (at the age of 71-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration on the left arm on 07Mar2021, at 10:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergy to iodine. The patient received unspecified concomitant medications. On 30Oct2020, the patient underwent SARS-CoV-2 test and the result was negative. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Feb2021 at 14:15, the patient experienced dizziness and vomiting. It was reported that the patient had severe dizziness and vomiting; at 1st dose, after about 4 hours and lasted for 6 hours. At 2nd dose, after about 24 hours and lasted for 12 hours, and still not fully recovered the next day. The dizziness was very strong that he felt the whole world was turning, and his stomach vomited whatever he had and tried to eat or drink. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event dizziness and vomiting was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791884
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM-9809) via an unspecified route of administration in the left arm on 26Feb2021 at 12:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), polycarbophil calcium (FIBER), multivitamins (MANUFACTURER UNKNOWN); all medications from an unknown date and unknown if ongoing for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL-9261) via an unspecified route of administration in the right arm on 05Feb2021 at 12:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 28Feb2021 at 14:30, the patient experienced swollen lymph nodes in armpit. On 28Feb2021 at 19:00, the patient experienced severe vomiting and diarrhea. The patient was surprised that these symptoms did not start until 48 plus hours after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes in armpit, severe vomiting and diarrhea were resolved on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS; CALCIUM; FIBER

Current Illness:

ID: 1791885
Sex: M
Age:
State: NY

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Bad sore throat; swollen lymph nodes; arm pain at the injection site three hours after injection.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 12:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, obesity and allergy to tomatoes, white potatoes, blueberries and cranberries. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included labetalol (MANUFACTURER UNKNOWN), telmisartan (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL); all for unknown indication from unknown date and unknown if ongoing. The patient previously received levofloxacin (LEVAQUIN) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021 at 15:45, three hours after injection, the patient experienced arm pain at the injection site. On 02Mar2021, the next day, the patient experienced swollen lymph nodes. On 03Mar2021, the third day, the patient experienced bad sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pain at the injection site, swollen lymph nodes and bad sore throat was recovering at this time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LABETALOL; TELMISARTAN; ADVIL [IBUPROFEN]

Current Illness:

ID: 1791886
Sex: M
Age:
State: IL

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: "I" have a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obsessive compulsive disorder, hypertension and hyperuricemia. The patient had known allergy only to pollens and mold. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other unspecified concomitant medications. On 27Feb2021 at 20:30, the patient experienced a red area around the injection site. It was oval-shaped and 3 inches long by 1 1/2 inches wide. It was reported that, this had been there since he got the injection and does not seem to had gotten any smaller despite and this being the 10th day after the vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event the patient had a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791887
Sex: F
Age:
State: OK

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: "I" was having a jittery episode, like the kind that happens when "I" take a steroid. It lasted until about 2a/could not be still; I was exhausted; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 07:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included sleep apnea, anxiety, depression, overweight and allergy to sulfa drugs(sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. On 03Mar2021 the patient was fine until 22:30. Then while patient was in bed, patient was having a jittery episode, like the kind that happens when patient took a steroid. It lasted until about 02:00. The patient heart was not racing, was not fast breathing. but patient could not be still and though patient was exhausted, could not rest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event jittery episode and exhausted, could not rest was recovered on 04Mar2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: FLUOXETINE

Current Illness:

ID: 1791888
Sex: F
Age:
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Feeling extremely weak approximately 9 hours after and the following day.; Slight discomfort at the injection site; Swelling of the upper arm area; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 10:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had known allergies to penicillin and shellfish. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received neomycin sulfate; polymyxin b sulfate; bacitracin (NEOSPORIN) and experienced drug allergy. On 03Mar2021 at 20:00 the patient felt extremely weak approximately 9 hours after and the following day. Slight discomfort at the injection site with noticeable swelling of the upper arm area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events felt extremely weak, slight discomfort at the injection site and swelling of the upper arm area was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791889
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Headache; Malaise; Nausea; Diarrhea; High blood pressure; Medical history given as High blood pressure (HBP) and event was also high blood pressure.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 16:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included myasthenia gravis, Hashimoto's and High Blood Pressure (HBP). The patient was allergic to tricyclics, benzopene and nut products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medication within 2 weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient previously received cyclobenzaprine hydrochloride (FLEXERIL) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Feb2021 at 15:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 08Mar2021 at 16:00, the patient experienced headache, malaise, nausea, diarrhea and high blood pressure. The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, malaise, nausea, diarrhea and high blood pressure were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791890
Sex: F
Age:
State: MA

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Pain; swelling and redness at injectionsite; swelling and redness at injectionsite; Runny nose; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 09Mar2021 at 15:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure (HBP), hyperlipidemia, depression and obesity. The patient received concomitant medications within two weeks, but were not specified. The patient previously received bupropion hydrochloride (WELLBUTRIN) from an unknown date and experienced allergy to the medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021 at 15:45, the patient experienced pain, swelling and redness at injection site and runny nose. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, swelling and redness at injection site and runny nose was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791891
Sex: M
Age:
State: MN

Vax Date: 02/23/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: vomited 44 times that day I could not keep anything in my stomach; extreme pain in my stomach area and in intestine area; extreme pain in my stomach area and in intestine area; sick; This is a spontaneous report from a contactable consumer (patient) via regulatory authority. This male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6200) via an unspecified route of administration in the left arm on 23Feb2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included heart disease from an unknown date and unknown if ongoing. Prior to vaccination the patient had not been diagnosed with COVID-19, had not received any other vaccines within 4 weeks and had no known allergies. The patient received unspecified concomitant medications within 2 weeks of vaccination. On 25Feb2021, the patient got up in the morning and went to work; he reported he was in extreme pain in the stomach area and in the intestine area and vomited 44 times that day. He reported he could not keep anything in his stomach, which lasted 4 days; further stating he could not even take his daily medications which were critical to him. He stated he was never so sick in his life and would not be getting the second dose. The events required a doctor's office visit, and no treatment was received. The clinical outcomes of the events were recovering. Since vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1791892
Sex: F
Age:
State: MI

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Indigestion; Chills; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 25Feb2021 at 09:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies possibly sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included testosterone enanthate (ARNOLD), losartan (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), pravastatin (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 13:45 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021, the patient experienced indigestion and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events indigestion and chills were recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ARNOLD; LOSARTAN; METOPROLOL; PRAVASTATIN; OMEPRAZOLE

Current Illness:

ID: 1791893
Sex: F
Age:
State: NJ

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Dizziness, lightheaded; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 17:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate (ADDERALL) and lamotrigine (LAMICTAL) all from an unknown date for an unknown indication and was unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 03Mar2021, the patient experienced dizziness and lightheaded. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness and lightheaded was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL; LAMICTAL

Current Illness:

ID: 1791894
Sex: M
Age:
State: OR

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Significant worsening of tinnitus.; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 27Feb2021 at 07:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 28Feb2021, the patient experienced significant worsening of her tinnitus. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event significant worsening of tinnitus was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791895
Sex: F
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Vaccine administered at inappropriate site; Dizzy; Anxious; Nausea; This is a spontaneous report from a contactable pharmacist. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via intramuscular route of administration in the left leg on 01Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Mar2021, the patient experienced dizzy, anxious and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ondansetron. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events dizzy, anxious and nausea were recovered on an unknown date in Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791896
Sex: F
Age:
State: NY

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Exhaustion; Very sore; Swollen arm; Foggy brain; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 04Mar2021 at 16:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included major depressive disorder, anxiety, high cholesterol and glaucoma. The patient previously received erythromycin (E-MYCIN), tetracycline hydrochloride (SUMYCIN), quinine sulfate (QUININE) and trazodone hydrochloride (DEPRAX) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID -19.Concomitant medications included fluoxetine hydrochloride (PROZAC), simvastatin (MANUFACTURER UNKNOWN), calcium levomefolate (DEPLIN) and latanoprost (MANUFACTURER UNKNOWN); all for an unknown indication, from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. On 05Mar2021 at 12:00, the patient experienced exhaustion, very sore, swollen arm, and foggy brain. The events did not result in doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events exhaustion, very sore, swollen arm and foggy brain was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PROZAC; SIMVASTATIN; DEPLIN [CALCIUM LEVOMEFOLATE]; LATANOPROST

Current Illness:

ID: 1791897
Sex: F
Age:
State: PA

Vax Date: 02/10/2021
Onset Date: 02/12/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Left temple Migraine; Random temple pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 10Feb2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Jan2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 12Feb2021 at 12:00, 2 days after the vaccination, the patient experienced left temple migraine which lasted for 4 days or so. She also experienced random temple pain on and off for days where she never had a headache like that. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left temple migraine and random temple pain was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791898
Sex: F
Age:
State: GA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Sore under arm pit couldn't raise it . Although it has improved it still hurts.; Sore under arm pit couldn't raise it .; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the right arm on 27Feb2021 at 09:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as yes (unspecified). The patient had allergies to medications, food or other products (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 27Feb2021 at 09:00, the patient experienced sore under arm pit, couldn't raise it. Although it had improved it still hurt. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore under arm pit, couldn't raise it was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791899
Sex: F
Age:
State:

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Headache at crown of head.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Mar2021 at 14:45 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO), trazodone (MANUFACTURER UNKNOWN) and alprazolam (XANAX) for unknown indication from an unknown date and unknown if ongoing. The patient previously took naproxen (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 09Mar2021 at 19:00, the patient experienced headache at crown of head. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache at crown of head was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO; TRAZODONE; XANAX

Current Illness:

ID: 1791900
Sex: F
Age:
State: MI

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Under left armpit swelling; Under left armpit pinching pain; This is a spontaneous report from a contactable consumer, the patient. An adult non-pregnant female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 08Mar2021 at 10:15 as a single dose for COVID-19 immunisation. Medical history included hemorrhoids. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included vitamin d nos (reported as generic: VITAMIN D) and ascorbic acid, betacarotene, biotin, calcium carbonate, calcium pantothenate, chromic chloride, colecalciferol, cupric oxide, cyanocobalamin, dl-alpha tocopheryl acetate, ferrous fumarate, folic acid, magnesium oxide, manganese sulfate, nicotinamide, phytomenadione, pyridoxine hydrochloride, retinol acetate, riboflavin, sodium selenate, thiamine mononitrate, zinc oxide (ONE A DAY WOMEN'S) for unknown indications from unknown dates and unknown if ongoing. On 09Mar2021 at 19:00, the patient experienced under left arm pit swelling and pinching pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events under left arm pit swelling and pinching pain was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; ONE A DAY WOMEN'S

Current Illness:

ID: 1791901
Sex: F
Age:
State: CA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Tongue soreness; Anxiety; This is a spontaneous report from a contactable pharmacist. A 46-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an intramuscular route of administration in the left arm on 22Feb2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 22Feb2021, the patient experienced tongue soreness and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events tongue soreness and anxiety was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1791902
Sex: F
Age:
State:

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Headache; Muscle ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the right arm on 04Feb2021 and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 01Mar2021 (both at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 04Feb2021, the patient experienced headache, muscle ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, muscle ache and fatigue was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791903
Sex: F
Age:
State: NE

Vax Date: 02/25/2021
Onset Date: 03/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: feeling lightheaded; I went to bed as I was feeling lightheaded and exhausted; After dinner last night, I started to feel nauseated; vomited a small amount of digested food; immediately developed a headache; immediately developed a chills, required extra blankets for warmth and cycled through hot/chilling cycles all night; required extra blankets for warmth and cycled through hot/chilling cycles all night; I had severe stomach pain; This is a spontaneous report from a contactable nurse. A 73-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the right arm on 25Feb2021 at 15:45 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included transient ischemic attack (TIA), tinnitus and lactose intolerance. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included tilactase (LACTASE), magnesium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and acetylsalicylic acid (BABY ASPIRIN); all for an unknown indication from an unknown dates and unknown if ongoing. On 04Mar2021 at 19:00, the patient felt nauseated after dinner and vomited a small amount of digested food, immediately developed a headache and chills. The patient reported that her husband completed his second Pfizerer dose, ate the same dinner and did not have any effects. On the same day at 20:00, the patient went to bed and was feeling lightheaded and exhausted 2 hours ahead of schedule. she required extra blankets for warmth and cycled through hot and chilling cycles all night, had severe stomach pain, but no diarrhea or coughing. At 06:00, effects disappeared with the exception of light headedness and exhaustion. The patient also reported that her 77-year-old sister received the Moderna vaccine on 22Feb2021 and had a massive stroke on 23Feb2021. That left her to wonder if she should get the second dose on 18Mar2021 or not. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nauseated, vomited, headache, hot chilling cycles, severe stomach pain, and chills were recovered on an unknown date in Mar2021, while the events feeling lightheaded and exhausted were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LACTASE; MAGNESIUM; VITAMIN D NOS; BABY ASPIRIN

Current Illness:

ID: 1791904
Sex: F
Age:
State: IN

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Since receiving 2nd dose of vaccine have had abdominal cramping and diarrhea daily; Since receiving 2nd dose of vaccine have had abdominal cramping and diarrhea daily; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Jan2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included HTN (hypertension), anxiety, GERD (gastroesophageal reflux disease), COVID-19 on an unknown date in Mar2020 along with pain stomach and diarrhea. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date in Mar2020. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included omeprazole (PRILOSEC), valsartan (MANUFACTURER UNKNOWN), venlafaxine hydrochloride (EFFEXOR) and melatonin (MANUFACTURER UNKNOWN); all for unspecified indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an 23Dec2020 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On an unknown date, the patient underwent 6-week V-safe check in and did mention possible complication. On 14Jan2021 after second dose, the patient experienced abdominal cramping and diarrhea daily. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events abdominal cramping and diarrhea were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PRILOSEC [OMEPRAZOLE]; VALSARTAN; EFFEXOR; MELATONIN

Current Illness:

ID: 1791905
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown if the patient was pregnant. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced fatigue. The clinical outcome of the event fatigue was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791906
Sex: F
Age:
State: TN

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Woke up in sweat; Pounding headache/ severe headache; Feeling super weak/ Too weak to get out of bed rest of day.; Dizzy; Started throwing up x3; Fell asleep and only woke up to intermediate alarms/ Was awake for a total of 2.5 hours before falling asleep again; Started feeling severely nauseous; Fatigued; This is a spontaneous report from a contactable other healthcare professional, the patient. A 22-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 03Mar2021 at 14:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), diagnosed with ovarian cyst on 01Mar in an unknown year and gluten intolerance (allergy to gluten). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) daily for an unknown indication, from an unknown date and hydrocodone (MANUFACTURER UNKNOWN) on 01Mar2021 and 02Mar2021, for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 10Feb2021 at 14:45 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 03Mar2021 at 20:30, the patient started feeling severely nauseous and fatigued, fell asleep and slept through the night until 07:15. On 04Mar2021 at 07:15, the patient woke up in sweat, pounding headache, feeling super weak and dizzy, tried to get water but started throwing up 3 times, fell asleep and only woke up to intermediate alarms the patient set for herself, was too weak to get out of bed rest of day and was awake for a total of 2.5 hours before falling asleep again at 18:30 and waking up at 06:15 on 05Mar2021. On 05Mar2021, the patient felt better than the previous day but still had a severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling severely nauseous and fatigued, fell asleep and slept through the night until 07:15, woke up in sweat, pounding headache, feeling super weak and dizzy, tried to get water but started throwing up 3 times, too weak to get out of the bed rest of the day, was awake for a total of 2.5 hours before falling asleep again and severe headache were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ADDERALL; HYDROCODONE

Current Illness:

ID: 1791907
Sex: F
Age:
State: KY

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Evening of 4th when arm pain disappeared digestive upset and diarreha resulted and continued throughout the night.; Evening of 4th when arm pain disappeared digestive upset and diarreha resulted and continued throughout the night.; Arm pain for two days; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 11:45 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and pulmonary embolism [on blood thinners for pulmonary embolism (PE) in 2013]. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and rivaroxaban (XARELTO); both for unknown indication from an unknown date and unknown if ongoing. On 03Mar2021 at 14:00, the patient experienced arm pain for two days and on 04Mar2021, in the evening, when arm pain disappeared digestive upset and diarrhea resulted and continued throughout the night. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event arm pain for two days was recovered on 04Mar2021 and the events digestive upset and diarrhea resulted and continued throughout the night was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; XARELTO

Current Illness:

ID: 1791908
Sex: M
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Tired; Soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 01Mar2021 at 14:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 06Feb2021 at 15:00 as a single dose for COVID-19 immunisation. On 03Mar2021 at 12:00, the patient experienced tired and soreness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tired and soreness was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791909
Sex: M
Age:
State: MD

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 03Mar2021 at 10:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication, from an unknown date and unknown if ongoing. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 10Feb2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 04Mar2021, the following morning after vaccination, the patient experienced running nose that lasted all day. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event running nose was resolved on 04Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1791910
Sex: M
Age:
State: AZ

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: The skin area around the injection (approximately 1 inch in diameter) felt dry and rough; The skin area around the injection (approximately 1 inch in diameter) felt dry and rough; At end of the injection, there was a pop from the needle; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an unspecified route of administration in the left arm on 13Feb2021 at 14:45 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included calcium carbonate/colecalciferol (CALCIUM+VIT D), cyanocobalamin (VITAMIN B-12), tocopherol (VITAMIN E), tamsulosin (MANUFACTURER UNKNOWN) and multi vit; all for unknown indications from unknown dates and unknown if ongoing. It was reported that at end of the Pfizer injection, there was a pop from the needle, and the nurse told sorry and startled, then the nurse added a band-aid, then sent the patient and his wife on down the driving line. On 16Feb2021 at 14:00, a few days later after removing the band-aid, the patient noticed that the skin area around the injection (approximately 1 inch in diameter) felt dry and rough. No redness nor swelling or pain was there. On 04Mar2021, the skin still had the same dry, rough texture feeling when the patient rubbed his finger over that area. The patient did not know if the vaccine caused this skin reaction, like when they heard the pop might be some of the vaccine popped and dribbled on his left arm around the injection area. Anyway, the patient would like to know if this was the cause of the dry, rough skin area or any other ideas we might have and how long would this area take to get back to normal. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events the skin area around the injection (approximately 1 inch in diameter) felt dry and rough. The clinical outcome of the events the skin area around the injection (approximately 1 inch in diameter) felt dry and rough was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TAMSULOSIN; CALCIUM+VIT D [CALCIUM CARBONATE;COLECALCIFEROL]; VITAMIN B-12; VITAMIN E [TOCOPHEROL]

Current Illness:

ID: 1791911
Sex: M
Age:
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chills (mild); Headache (mild); Fatigue (mild); Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 13:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19 . The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 13:15, the patient experienced injection site pain (mild). On 04Mar2021, the patient experienced injection site pain (mild), chills (mild), headache (mild) and fatigue (mild). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site pain (mild), injection site pain (mild), chills (mild), headache (mild) and fatigue (mild) were resolved on an unknown date in Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am